Up- regulation of miR-328-3p sensitizes non-small cell lung cancer to radiotherapy

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Ma, Wei ^a   Ma, Chao Nan ^a   Zhou, Nan Nan ^a   Li, Xian Dong ^a   Zhang, Yi Jie ^a  

^a HENAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN328 MICRORNA, HUMAN;

A-549 CELL LINE; DNA DAMAGE; GENETICS; HUMAN; LUNG TUMOR; NON SMALL CELL LUNG CANCER; RADIATION TOLERANCE; UPREGULATION;

A549 CELLS; CARCINOMA, NON-SMALL-CELL LUNG; DNA DAMAGE; HUMANS; LUNG NEOPLASMS; MICRORNAS; RADIATION TOLERANCE; UP-REGULATION;

EID: 84983247295     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep31651     Document Type: Article

References (50)

1. Jemal, A. et al. Global cancer statistics. CA. Cancer. J. Clin. 61, 69-90 (2011)
2. Ettinger, D. S., Akerley, W. & Borghaei, H. Non-small cell lung cancer: clinical practice guidelines in oncology. J. Natl. Compr. Canc. Netw. 10, 1236-71 (2012)
3. Webb, S. Advances in three-dimensional conformal radiation therapy physics with intensity modulation. Lancet. Oncol. 1, 30-6 (2000)
4. Hennon, M. W. & Yendamuri, S. Advances in lung cancer surgery. J. Carcinog. 11, 21 (2012)
5. Saadeddin, A. Radiotherapy for NSCLC: review of conventional and new treatment techniques. J. Infect. Public. Health. 5, S45-49 (2012)
6. Joubert, A. & Foray, N. Intrinsic radiosensitivity and DNA double-strand breaks in human cells. Cancer. Radiother. 11, 129-142 (2007)
7. Anastasov, N. et al. Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cells. Radiat. Oncol. 7, 206 (2012)
8. Hinz, J. M., Yamada, N. A., Salazar, E. P., Tebbs, R. S. & Thompson, L. H. Influence of double-strand-break repair pathways on radiosensitivity throughout the cell cycle in CHO cells. DNA. Repair. 4, 782-92 (2005)
9. Xu, Y. M. et al. Regulaton of miRNAs affects radiobioloical response of lung cancer stem cells. Biomed. Res. Int. 15, 851841, doi: 10.1155/2015/851841 (2015)
10. Shen, Z., Wu, X., Wang, Z., Li, B. & Zhu, X. Effect of miR-18a overexpression on the radiosensitivity of non-small cell lung cancer. Int. J. Clin. Exp. Pathol. 8, 643-8 (2015)
11. Korpela, E., Vesprini, D. & Liu, S. K. MicroRNA in radiotherapy: miRage or miRador? Br. J. Cancer. 112, 77-82 (2015)
12. Yan, D. et al. Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. Plos. One. 5, e11397. doi: 10.1371/journal. pone.0011397 (2010)
13. Moskwa, P. et al. miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Mol. Cell. 241, 210-20 (2011)
14. Lal, A. et al. miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells. Nat. Struct. Mol. Biol. 16, 492-8 (2009)
15. Hu, H., Du, L., Nagabayashi, G., Seeger, R. C. & Gatti, R. A. ATM is down-regulated by N-Myc-regulated microRNA-421. Proc. Natl. Acad. Sci. USA. 107, 1506-11 (2010)
16. Bader, A. G., Brown, D. & Winkler, M. The promise of microRNA replacement therapy. Cancer. Res. 70, 7027-30 (2010)
17. Petrocca, F. & Lieberman, J. Promise and challenge of RNA interference based therapy for cancer. J. Clin. Oncol. 29, 747-54 (2011)
18. Cellini, F. et al. Role of microRNA in response to ionizing radiations: evidences and potential impact on clinical practice forradiotherapy. Molecules. 19, 5379-401 (2014)
19. Yongchun, Z. et al. MicroRNA-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting MYB. Cancer. Lett. 347, 65-74 (2014)
20. Meng, W. et al. MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma. Clin. Cancer. Res. 19, 5423-33 (2013)
21. Zang, Y. S. et al. MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression. Cancer. Gene. Ther. 19, 773-8 (2012)
22. Xiong, S. PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer. Br. J. Cancer. 110, 353-62 (2014)
23. Chen, S., Sun, K. X., Liu, B. L., Zong, Z. H. & Zhao, Y. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α . Mol. Cancer. 15, 11 (2016)
24. Cortez, M. A. et al. Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer. Mol. Ther. 22, 1494-503 (2014)
25. Kumar, M. S. et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA. 105, 3903-8 (2008)
26. Ma, W., Ma, C. N., Li, X. D. & Zhang, Y. J. Examining the effect of gene reduction in miR-95 and enhanced radiosensitivity in nonsmall cell lung cancer. Caner. Gene. Ther. 22, 66-71 (2016)
27. Du, W. W. et al. MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling. J. Cell. Sci. 126 (Pt 6), 1440-53 (2013)
28. Wang, X. C. et al. Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer. Lung. Cancer. 72, 92-9 (2011)
29. Li, W. Q. et al. Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance. Med. Sci. Monit. 16, HY27-30 (2010)
30. Pan, Y. Z. et al. MicroRNA-328 negatively regulates the expression of breast cancer resistance protein(BCRP/ABCG2) in human cancer cells. Mol. Pharmacol. 75, 1374-79 (2009)
31. Xu, X. T. et al. MicroRNA expression profiling identifies miR-328-3p regulates cancer stem cell-like SP cells in colorectal cancer. Br. J. Cancer. 106, 1320-30 (2012)
32. Liu, L. et al. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia. Diagn Pathol. 10, 109 (2015)
33. Weidhaas, J. B. et al. MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer. Res. 67, 11111-11116 (2007)
34. Oh, J. S., Kim, J. J., Byun, J. Y. & Kim, I. A. Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras. Int. J. Radiat. Oncol. Biol. Phys. 76, 5-8 (2010)
35. Arora, H. et al. miR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFkappaB1. Exp. Mol. Med. 43, 298-304 (2011)
36. Chen, S. et al. Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level. Int. J. Radiat. Oncol. Biol. Phys. 81, 1524-29 (2011)
37. Shin, S. et al. Alteration of miRNA profiles by ionizing radiation in A549 human non-small cell lung cancer cells. Int. J. Oncol. 35, 81-86 (2009)
38. Lal, A. et al. miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells. Nat. Struct. Mol. Biol. 16, 492-8 (2009)
39. Pothof, J. et al. MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response. EMBO. J. 28, 2090-9 (2009)
40. Li, M. et al. Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3. Sci. Rep. 6, 23100 (2016)
41. Liu, Y. J. et al. MicroRNA-449a enhances radiosensitivity in CL1-0 lung adenocarcinoma cells. Plos. One. 8, e62383, doi: 10.1371/ journal.pone.0062383 (2013)
42. Di Francesco, A. et al. The DNA-damage response to gamma-radiation is affected by miR-27a in A549 cells. Int. J. Mol. Sci. 14, 17881-17896 (2013)
43. Bassing, C. H. et al. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc. Natl. Acad. Sci. USA. 99, 8173-8 (2002)
44. Celeste, A. et al. Genomic instability in mice lacking histone H2AX. Sciences. 296, 922-7 (2002)
45. Wang, Y. et al. MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression. Mol. Cancer. Res. 9, 1100-11 (2011)
46. Piemonte, M. TNM-classification of malignant tumors (VI edition-2002). Innovations in the classification of head and neck neoplasms. Acta Otorhinolaryngol. Ital. 23, 132-5 (2003)
47. Fujimori, H. et al. Comprehensive analysis of radiosensitization targets; functional inhibition of DNA methyltransferase 3B radiosensitizes by disrupting DNA damage regulation. Sci. Rep. 5, 18231 (2015)
48. Kang, M. A. et al. DNA damage induces reactive oxygen species generation through the H2AX-Nox/Rac1 pathway. Cell. Death. Dis. 3, e249 (2012)
49. Solberg, N. & Krauss, S. Luciferase assay to study the activity of a cloned promoter DNA fragment. Methods. Mol. Biol. 7, 65-78 (2013)
50. Olive, P. L. & Banath, J. P. The comet assay: a method to measure DNA damage in individual cells. Nat. Protoc. 1, 23-9 (2006)